Table 2.
MicroRNA | Associated fibrotic skin diseases |
Notable targets | Key skin fibrotic processes |
References |
---|---|---|---|---|
Let-7a | Scleroderma | Collagen type I | ECM synthesis | [38] |
miRNA-7 | Localized scleroderma, keloids |
Collagen type I | ECM synthesis | [15] |
MiRNA-17- 5p |
Hypertrophic scars |
TGFβ2R | TGF-β signaling | [51] |
MiRNA-18 | Hypertrophic scars |
Smad4 | TGF-β signaling | [51] |
MiRNA-20 | Hypertrophic scars |
TGFβ2R | TGF-β signaling | [51] |
miRNA-26a | Scleroderma, keloids |
Collagen type I | ECM synthesis | [15] |
miRNA-29 | Scleroderma | Collagen types I and III, elastin, fibrillin, Wnt/beta catenin, NF-κ, BMAPK |
ECM synthesis | [11,19,41,49, 78] |
miRNA-129- 5p |
Scleroderma, keloids |
Collagen type I | ECM synthesis | [15] |
miRNA-133a | Scleroderma | Collagen types V and VI | ECM synthesis | [34] |
miRNA- 133b |
Scleroderma, keloids |
Collagen type I | ECM synthesis | [15] |
miRNA-140- 5p |
Scleroderma | TFGβ2R | TGF-β signaling | [34] |
Collagen type I | ECM synthesis | [34] | ||
miRNA-145 | Scleroderma | Smad3 | TGF-β signaling | [78] |
miRNA-150 | Scleroderma | Integrin β3 (indirectly collagen type I |
ECM synthesis | [21] |
miRNA-196a | Scleroderma, keloids |
Collagen types I and III | ECM synthesis | [20,29] |
miRNA-200 | Keloids | Zeb1, Zeb2, TGF-β2 | Epithelial-to- mesenchymal transition |
[8,44] |
miRNA-203 | Keloids | MAPK, TGF-β, and the synthesis of collagen |
ECM synthesis | [36] |
miRNA-205 | Keloids | MAPK, TGF-β, and the synthesis of collagen |
ECM synthesis | [36] |
miRNA-206 | Scleroderma | TFGβ1, TFGβ2 | TGF-β signaling | [34] |
Collagen types VI and XIX | ECM synthesis | [34] |